Page last updated: 2024-09-03

reboxetine and Liver Dysfunction

reboxetine has been researched along with Liver Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benedetti, MS; Dostert, P; Poggesi, I	1

Reviews

1 review(s) available for reboxetine and Liver Dysfunction

Article	Year
Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1997, Volume: 7 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Age Factors; Animals; Antidepressive Agents; Area Under Curve; Biological Availability; Brain; Food-Drug Interactions; Humans; Kidney Diseases; Liver; Liver Diseases; Morpholines; Reboxetine; Stereoisomerism	1997

Article

Year

Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1997, Volume: 7 Suppl 1

Topics: Adrenergic Uptake Inhibitors; Age Factors; Animals; Antidepressive Agents; Area Under Curve; Biological Availability; Brain; Food-Drug Interactions; Humans; Kidney Diseases; Liver; Liver Diseases; Morpholines; Reboxetine; Stereoisomerism

1997